GLP-1 Medications for Type 1 Diabetes
US$ 27.92
join retatrutide trial With approaching ~30% weight loss at 2 years—but with what appears to be a meaningfully higher adverse event burden than earlier-generation incretin therapies—expert clinical guidance… Retatrutide – Peptid24
Description
Iacobellis G, Malavazos AE
In the intestine and pancreas, GLP-1 is produced and secreted upon meal ingestion, and after its release, it acts as an incretin and is involved in satiation signaling (Holst, 2007)
This can help reduce appetite and make it easier to eat less
In addition to assisting with significant, sustained weight loss, tirzepatide improves metabolic health by enhancing blood sugar control, lowering blood pressure, and positively affecting cholesterol levels
), with 94% homology to human GLP-1, were approved in 2019 as the first GLP-1R agonists for oral administration (Ke et al., 2024) (Table 2)
